The European Medicines Agency's EU conditional marketing authorisations for COVID-19 vaccines
Lancet
.
2021 Jan 30;397(10272):355-357.
doi: 10.1016/S0140-6736(21)00085-4.
Epub 2021 Jan 13.
Authors
Marco Cavaleri
1
,
Harald Enzmann
2
,
Sabine Straus
3
,
Emer Cooke
4
Affiliations
1
European Medicines Agency, 1083 HS Amsterdam, Netherlands. Electronic address: marco.cavaleri@ema.europa.eu.
2
European Medicines Agency, 1083 HS Amsterdam, Netherlands; Federal Institute for Drugs and Medical Devices, European Union and International Affairs, Bonn, Germany.
3
European Medicines Agency, 1083 HS Amsterdam, Netherlands; Medicines Evaluation Board, Utrecht, Netherlands.
4
European Medicines Agency, 1083 HS Amsterdam, Netherlands.
PMID:
33453149
PMCID:
PMC7833511
DOI:
10.1016/S0140-6736(21)00085-4
No abstract available
MeSH terms
COVID-19 / prevention & control*
COVID-19 Vaccines*
Drug Approval*
European Union*
Humans
Marketing of Health Services*
Substances
COVID-19 Vaccines